Physician profile
Juli D White
NPI 1821456765
$4,074.45
in general payments reported to CMS, 2019-2025
42 companies · $17.82 in 2025
The $17.82 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,107 · 2022: $1,573 · 2023: $1,158 · 2024: $219 · 2025: $17.82.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,329 · Education: $64.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,329.39 |
| Education | $64.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Harmony Biosciences LLC | $764.03 | 2021-2023 | Wakix |
| Novo Nordisk INC | $365.57 | 2021-2024 | Ozempic, Rybelsus, Wegovy |
| Jazz Pharmaceuticals INC. | $356.53 | 2021-2022 | |
| Abbvie INC. | $317.11 | 2021-2024 | |
| Amgen INC. | $301.41 | 2021-2024 | Evenity, Prolia, Otezla |
| Lilly USA, LLC | $214.11 | 2021-2024 | Mounjaro, Jardiance, Emgality |
| Pfizer INC. | $177.00 | 2021-2025 | |
| Vanda Pharmaceuticals INC. | $140.42 | 2021-2023 | Hetlioz, Fanapt |
| Merck Sharp & Dohme LLC | $128.37 | 2021-2023 | Belsomra |
| Paratek Pharmaceuticals, INC. | $113.57 | 2021-2023 | Nuzyra |
| Bayer Healthcare Pharmaceuticals INC. | $98.35 | 2021-2023 | |
| Otsuka America Pharmaceutical, INC. | $78.40 | 2021-2023 | Rexulti |
| Axsome Therapeutics, INC. | $75.87 | 2022-2023 | Sunosi |
| Boehringer Ingelheim Pharmaceuticals, INC. | $73.72 | 2021-2024 | Jardiance |
| E.R. Squibb & Sons, L.L.C. | $65.21 | 2021-2023 | Eliquis |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Juli White listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.